Why is Nuscale Power stock down 6% today?

Nuscale Power's stock dropped 6.5% in pre-market trading after Barclays downgraded it to Underweight and cut its price target to $5 from $11. The company faces multiple analyst downgrades, legal investigations, and dilution concerns. Its stock is near a 52-week low of $5.44, with weak customer commitments and expected negative free cash flow contributing to the decline.

Original reporting
Published Oct 20, 2026, 10:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 11:17 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$SMR
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

High
01

Why it matters

The latest downgrade deepens the bearish narrative, likely extending the stock's decline in the near term.

02

Market read

The article explains a fresh analyst downgrade that directly caused a 6% pre‑market drop, making it a market‑mover event for NS.

03

What to watch

Potential future government contracts for SMR technology could provide a catalyst that outweighs current short‑term concerns.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

NuScale Power is a pre‑revenue small modular reactor developer that has been under pressure from analyst downgrades and a pending securities fraud probe.

Market effects

Negative sentiment spreads to other early‑stage SMR developers, pressuring the nuclear small‑modular‑reactor sector.

US small‑cap and pre‑revenue stocks face broader weakness as investors shy from high‑beta speculative names.

Limited to investors in the nuclear energy and clean‑tech space; no immediate global macro impact.

Counterpoint

If the fraud investigation stalls and cash burn eases, the stock could be oversold and present a short‑term buying opportunity.

Key entities

  • Barclays

    Downgraded NuScale Power to Underweight and cut price target to $5.

  • Pomerantz LLP

    Launched a securities fraud investigation into NuScale.

Related articles

$SMRLowAI 8/10

NuScale Power Falls 7% as 10-Year Treasury Yield Climbs to 5.26%; Energy Fuels Drops 9%, Oklo Slides 5%

NuScale Power (SMR) fell 7% to $6.04, Energy Fuels (UUUU) dropped 9% to $8.43, and Oklo (OKLO) slid 5% to $30.11 as 10-year Treasury yields rose to 5.26%. The Global X Uranium ETF (URA) declined 4%, outpacing the broader market's 0.8% drop. Rising yields impact long-duration assets like nuclear developers, affecting both valuation and project financing costs.

$GOOGHighAI 8/10

Google Signed a Deal for Existing Reactors. So Why Did Oklo and NuScale Jump on the Constellation Energy News? The Read-Through Investors Are Missing.

Alphabet (GOOG, GOOGL) agreed to a 15-year and 20-year deal with Constellation Energy (CEG) for nuclear power, investing $4.3B in new capacity. Oklo (OKLO) and NuScale (SMR) shares also rose, despite no direct involvement. The companies develop small modular reactors (SMRs) for specific facilities, differing from Constellation's large-scale plants. Investors see broader nuclear energy growth, with SMRs expected to play a significant role by 2050, according to industry estimates.

$SMRMed

SMR Stock Slides As UBS Downgrade Triggers Legal Scrutiny

NuScale Power Corporation (NYSE: SMR) shares fell 3.13% on October 13, 2026, closing at $6.49. The decline follows a UBS downgrade from Neutral to Sell, with a price target cut from $10 to $6, citing concerns over delayed deployments, weak customer commitments, and cash burn. Additionally, Pomerantz LLP announced an investigation into potential securities fraud, adding to the uncertainty.

$SMRHigh

SMR Stock Slides As Fraud Probe Follows UBS Downgrade

NuScale Power Corporation (NYSE: SMR) shares fell 7.29% on October 12, 2026, amid concerns over project delays, a UBS downgrade, and a fraud probe. UBS cut its price target to $6, citing execution risks and negative free cash flow expectations. SMR reported Q2 2026 revenue of $75,000 and a net loss of $47.54M. Analysts' average price target is $12.37, with a consensus 'Hold' rating.

$SMRHigh

NuScale Power Is Now Down 49% This Year: Is SMR Stock Dead Money or Due for a Bounce?

NuScale Power (SMR) stock is down 49% year to date, trading at $7.18. The company reported $75,000 in quarterly revenue, a significant drop from the prior year, and plans to sell $750 million in shares. NuScale is a pre-revenue developer of small modular reactors, with no commercial deployment expected until the early 2030s. Investors debate whether the stock is dead money or a bounce candidate.